Page 41 - Product Testing News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Business Wire. The AP news staff was not involved in its creation. Europe Virtual Clinical Trials Market (2020 to 2026) - by Study Type, Indication and Country - ResearchAndMarkets.com February 16, 2021 GMT DUBLIN--(BUSINESS WIRE)--Feb 16, 2021-- ADVERTISEMENT Another name for virtual trials is decentralized trials. Virtual trials have a major role to play in the current COVID-19 pandemic and are likely to be a rule in the ways trials and real-world research are run. ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome ProQR Therapeutics N.V.February 16, 2021 GMT LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), t...

Press release content from Business Wire. The AP news staff was not involved in its creation. Eyevensys Named to French Tech 120 Program February 15, 2021 GMT PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 15, 2021-- Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today announced it has been accepted into the French Tech 120 program for 2021. This government-backed program, run by La French Tech, offers support for 1...

Press release content from Business Wire. The AP news staff was not involved in its creation. Lysogene Reports LYS-SAF302 Biomarker Data Presented at the WORLDSymposium™ 2021 February 15, 2021 GMT Regulatory News: Lysogene (Paris:LYS) (FR0013233475 – LYS), a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today reports biomarker data from the ongoing AAVance clinical trial with LYS-SAF302 for the treatment of MPS IIIA (NCT03612869) presented at the WO...

Press release content from Business Wire. The AP news staff was not involved in its creation. United States Prostate Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight to 2026 - ResearchAndMarkets.com February 15, 2021 GMT DUBLIN--(BUSINESS WIRE)--Feb 15, 2021-- ADVERTISEMENT Comprehensive Clinical Insight On 25 FDA Approved Prostate Cancer Drugs Drug Dosage, Patent, Price, Patent Insight Insight On 222 Prostate Cancer Drugs In Clinical Trials Clinical Trial Overview by Biomarker,...

Press release content from Business Wire. The AP news staff was not involved in its creation. VALBIOTIS Authorized to Launch HEART, the Phase II Multi-center Clinical Study With TOTUM-070, for the Reduction of Blood LDL-cholesterol Levels February 15, 2021 GMT LA ROCHELLE, France--(BUSINESS WIRE)--Feb 15, 2021-- VALBIOTIS (FR0013254851 – ALVAL / eligible for the PEA/SME, French equity savings plan for the financing of SMEs) (Paris:ALVAL), a Research & Development company committed to scientif...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

MINNEAPOLIS — Minnesota health officials urged this week that people wear masks — and wear them properly — as the state reported an additional 964 new infections on Saturday.

Press release content from Business Wire. The AP news staff was not involved in its creation. Global Mesenchymal Stem Cells Advances and Applications Market Report 2021 - ResearchAndMarkets.com February 12, 2021 GMT DUBLIN--(BUSINESS WIRE)--Feb 12, 2021-- As the most common stem cell type being used within regenerative medicine today, there is huge potential for growth within the MSC market. There are more than one-hundred thousand scientific publications published about MSCs, as well as over 1...